CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 4,432 Value ($000) $181 Avg Close Range
Q1 2024
Shares 36,528 Value ($000) $1,544 Avg Close Range
Q4 2023
Shares 36,782 Value ($000) $1,560 Avg Close Range
Q3 2023
Shares 32,786 Value ($000) $716 Avg Close Range
Q2 2023
Shares 32,786 Value ($000) $1,042 Avg Close Range
Q1 2023
Shares 30,419 Value ($000) $742 Avg Close Range
Q4 2022
Shares 30,419 Value ($000) $959 Avg Close Range
Q3 2022
Shares 28,841 Value ($000) $815 Avg Close Range
Q2 2022
Shares 28,841 Value ($000) $763 Avg Close Range
Q1 2022
Shares 25,158 Value ($000) $881 Avg Close Range
Q4 2021
Shares 15,873 Value ($000) $515 Avg Close Range
Q3 2021
Shares 15,873 Value ($000) $468 Avg Close Range
Q2 2021
Shares 15,873 Value ($000) $407 Avg Close Range